No Data
Harmony Biosciences Holdings, Inc.'s (NASDAQ:HRMY) Stock Been Rising: Are Strong Financials Guiding The Market?
Harmony Biosciences Holdings' (NASDAQ:HRMY) stock is up by 9.2% over the past three months. Since the market usually pay for a company's long-term financial health, we decided to study the company'
Wall Street Analysts See a 32.82% Upside in Harmony Biosciences (HRMY): Can the Stock Really Move This High?
Are Investors Undervaluing Harmony Biosciences (HRMY) Right Now?
Piper Sandler Maintains Harmony Biosciences(HRMY.US) With Buy Rating, Maintains Target Price $44
Piper Sandler analyst David Amsellem maintains $Harmony Biosciences(HRMY.US)$ with a buy rating, and maintains the target price at $44.According to TipRanks data, the analyst has a success rate of 42.
Piper Sandler Reaffirms Their Buy Rating on Harmony Biosciences Holdings (HRMY)
Harmony Biosciences Executive Resigns, Subsidiary Renamed